Scientists dive deep into Lymphedema's genetic roots
NCT ID NCT05629026
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand why lymphedema develops by comparing gene activity in swollen versus healthy limbs. Researchers will take tiny tissue samples from 60 adults with primary or secondary lymphedema. The goal is to identify molecular differences that could point toward future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal key molecular targets for future lymphedema treatments.
- What could go wrong
- This is an early observational study with only 60 participants, so findings may not lead directly to therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Toulouse Hospital
RECRUITINGToulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can swollen limbs throw off your balance? a study investigates
- Could reapplying compression bandages three times a day beat the standard Once-Daily treatment for lymphedema?
- New study aims to catch lymphedema early in breast cancer patients
- Sound waves could reveal hidden fluid in swollen limbs
- Exercise may cool down lymphedema in breast cancer survivors
- New method aims to make compression stockings easier to wear